In amongst a clutch of discontinued phase 3 programmes in Roche's fourth-quarter results update was the news that it has stopped a study of AKT inhibitor ipatasertib as a treatment for first-line ...

"Brain injury recovery involves much repetition,” he said. “The brain makes new pathways based on the demands that are applied to your life. If you sit down and rest all the time, your brain ...